Jacobs Levy Equity Management Inc. bought a new stake in shares of Spok Holdings, Inc. (NASDAQ:SPOK – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 78,092 shares of the Wireless communications provider’s stock, valued at approximately $1,253,000.
Several other institutional investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC increased its holdings in Spok by 67.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 110,997 shares of the Wireless communications provider’s stock worth $1,782,000 after acquiring an additional 44,896 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Spok by 2,263.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 198,419 shares of the Wireless communications provider’s stock worth $2,988,000 after acquiring an additional 190,024 shares in the last quarter. Barclays PLC increased its holdings in Spok by 273.8% in the 3rd quarter. Barclays PLC now owns 24,078 shares of the Wireless communications provider’s stock worth $362,000 after acquiring an additional 17,637 shares in the last quarter. Inspire Investing LLC acquired a new stake in Spok during the 4th quarter worth $801,000. Finally, Sanctuary Advisors LLC boosted its stake in Spok by 4.9% during the 4th quarter. Sanctuary Advisors LLC now owns 27,269 shares of the Wireless communications provider’s stock worth $439,000 after purchasing an additional 1,271 shares during the last quarter. 50.81% of the stock is owned by hedge funds and other institutional investors.
Spok Price Performance
NASDAQ SPOK opened at $16.94 on Friday. The firm’s 50-day moving average is $15.81 and its two-hundred day moving average is $16.14. Spok Holdings, Inc. has a 12 month low of $13.55 and a 12 month high of $17.96. The stock has a market capitalization of $348.49 million, a P/E ratio of 23.21 and a beta of 0.51.
Spok Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Friday, May 23rd will be paid a dividend of $0.3125 per share. The ex-dividend date is Friday, May 23rd. This represents a $1.25 dividend on an annualized basis and a yield of 7.38%. Spok’s dividend payout ratio (DPR) is presently 160.26%.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on SPOK shares. StockNews.com raised shares of Spok from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 10th. B. Riley raised shares of Spok to a “strong-buy” rating in a research report on Thursday, May 1st.
Get Our Latest Analysis on Spok
Insiders Place Their Bets
In related news, COO Michael W. Wallace sold 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $16.53, for a total value of $99,180.00. Following the completion of the transaction, the chief operating officer now directly owns 61,175 shares of the company’s stock, valued at $1,011,222.75. This represents a 8.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Vincent D. Kelly sold 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $16.40, for a total value of $492,000.00. Following the completion of the transaction, the chief executive officer now directly owns 157,817 shares of the company’s stock, valued at $2,588,198.80. This trade represents a 15.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 10.51% of the company’s stock.
About Spok
Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.
Featured Articles
- Five stocks we like better than Spok
- 3 Warren Buffett Stocks to Buy Now
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- P/E Ratio Calculation: How to Assess Stocks
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- How to Buy Cheap Stocks Step by Step
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Want to see what other hedge funds are holding SPOK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Spok Holdings, Inc. (NASDAQ:SPOK – Free Report).
Receive News & Ratings for Spok Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spok and related companies with MarketBeat.com's FREE daily email newsletter.